Oral and Vaginal Tenofovir for Genital Herpes Simplex Virus Type 2 Shedding in Immunocompetent Women: A Double-Blind, Randomized, Cross-over Trial

Background. Tenofovir is a potent anti-human immunodeficiency virus (HIV) agent that decreased risk of herpes simplex virus type 2 (HSV-2) acquisition in HIV pre-exposure prophylaxis trials. Whether tenofovir has utility in established HSV-2 disease is unclear. Methods. We randomized immunocompetent...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Infect Dis
Autors principals: Bender Ignacio, Rachel A., Perti, Tara, Magaret, Amalia S., Rajagopal, Sharanya, Stevens, Claire E., Huang, Meei-Li, Selke, Stacy, Johnston, Christine, Marrazzo, Jeanne, Wald, Anna
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2015
Matèries:
Major Articles and Brief Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4655855/
https://ncbi.nlm.nih.gov/pubmed/26044291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiv317
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars